[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Medical News and Perspectives
October 3, 2007

Dual Antithrombotic Therapy’s Increased Risks Not Always Offset by Benefit

JAMA. 2007;298(13):1504-1505. doi:10.1001/jama.298.13.1504

Mounting evidence indicates that dual anticoagulation and antiplatelet therapy is no more effective than monotherapy in treating a variety of cardiovascular conditions, but it does increase the risk of life-threatening bleeding.

“What's interesting is that while clinicians are aware of the potential bleeding complications with these antithrombotic drugs, they do not appreciate that the risk is not purely additive; it is synergistic,” said James M. Brophy, MD, PhD, associate professor of medicine in the Division of Cardiology and Clinical Epidemiology at McGill University Health Centre, in Montreal.

First Page Preview View Large
First page PDF preview
First page PDF preview
×